KINDERHOOK, N.Y.--(BUSINESS WIRE)--American Bio Medica Corporation (NASDAQ:ABMC) announced today that they have entered into a Purchase Agreement with one of the world’s largest clinical laboratories. The client has requested its name not be disclosed at this time however; ABMC describes the company as an S&P 500 listed company that performs millions of drugs of abuse tests annually. The laboratory will purchase ABMC’s point of collection drugs of abuse testing devices for use at locations strategically located throughout the United States.
